WO1999054460A3 - Sequences d'acide nucleique provenant du tissu normal de la vessie - Google Patents

Sequences d'acide nucleique provenant du tissu normal de la vessie Download PDF

Info

Publication number
WO1999054460A3
WO1999054460A3 PCT/DE1999/001163 DE9901163W WO9954460A3 WO 1999054460 A3 WO1999054460 A3 WO 1999054460A3 DE 9901163 W DE9901163 W DE 9901163W WO 9954460 A3 WO9954460 A3 WO 9954460A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
bladder tissue
human nucleic
normal bladder
Prior art date
Application number
PCT/DE1999/001163
Other languages
German (de)
English (en)
Other versions
WO1999054460A2 (fr
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Original Assignee
Metagen Gesellschaft Fuer Genomforschung Mbh
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagen Gesellschaft Fuer Genomforschung Mbh, Thomas Specht, Bernd Hinzmann, Armin Schmitt, Christian Pilarsky, Edgar Dahl, Andre Rosenthal filed Critical Metagen Gesellschaft Fuer Genomforschung Mbh
Priority to EP99924792A priority Critical patent/EP1071776A2/fr
Priority to JP2000544792A priority patent/JP2002531052A/ja
Publication of WO1999054460A2 publication Critical patent/WO1999054460A2/fr
Publication of WO1999054460A3 publication Critical patent/WO1999054460A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique humaines (ARNm, ADNc, séquences génomiques) provenant du tissu normal de la vessie, qui codent pour des produits géniques ou pour des parties desdits produits géniques, ainsi que leur utilisation. Elle concerne également les polypeptides codés par lesdites séquences et leur utilisation.
PCT/DE1999/001163 1998-04-21 1999-04-15 Sequences d'acide nucleique provenant du tissu normal de la vessie WO1999054460A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99924792A EP1071776A2 (fr) 1998-04-21 1999-04-15 Sequences d'acide nucleique provenant du tissu normal de la vessie
JP2000544792A JP2002531052A (ja) 1998-04-21 1999-04-15 正常膀胱組織由来ヒト核酸配列

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19818620.7 1998-04-21
DE19818620A DE19818620A1 (de) 1998-04-21 1998-04-21 Menschliche Nukleinsäuresequenzen aus Blase-Normal

Publications (2)

Publication Number Publication Date
WO1999054460A2 WO1999054460A2 (fr) 1999-10-28
WO1999054460A3 true WO1999054460A3 (fr) 2000-05-11

Family

ID=7865834

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001163 WO1999054460A2 (fr) 1998-04-21 1999-04-15 Sequences d'acide nucleique provenant du tissu normal de la vessie

Country Status (4)

Country Link
EP (1) EP1071776A2 (fr)
JP (1) JP2002531052A (fr)
DE (1) DE19818620A1 (fr)
WO (1) WO1999054460A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US20030170864A1 (en) 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL142794A0 (en) * 1998-12-16 2002-03-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
ES2261559T3 (es) * 1998-12-16 2006-11-16 Genentech, Inc. Polipeptidos secretados y transmenbrana asi como los acidos nucleicos que los codifican.
PT1626058E (pt) * 1999-03-08 2008-02-15 Genentech Inc Composições e métodos para o diagnóstico de tumores
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (fr) * 1999-07-08 2005-03-16 Research Association for Biotechnology Protéine sécrétoire ou protéine de membrane
US6387658B1 (en) 1999-09-23 2002-05-14 Rigel Pharmaceuticals, Inc. PCNA-associated cell cycle proteins, compositions and methods of use
WO2001072958A2 (fr) * 2000-03-28 2001-10-04 Beth Israel Deaconess Medical Center Peptides specifiques au cancer de la vessie utilises a des fins diagnostiques et therapeutiques
MXPA03000979A (es) * 2000-08-01 2004-08-12 Amgen Inc Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
US7189820B2 (en) 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)
WO2003046224A1 (fr) 2001-11-28 2003-06-05 The General Hospital Corporation Dosage sanguin permettant de deceler des dysferlinopathies
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045436A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. Marqueurs secretes de sequence exprimee (sest)
WO1999006550A2 (fr) * 1997-08-01 1999-02-11 Genset Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
WO1999006551A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees identifiees dans le tissu cerebral
WO1999031236A2 (fr) * 1997-12-17 1999-06-24 Genset ADNc PROLONGES POUR PROTEINES SECRETEES

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045436A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. Marqueurs secretes de sequence exprimee (sest)
WO1999006550A2 (fr) * 1997-08-01 1999-02-11 Genset Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
WO1999006551A2 (fr) * 1997-08-01 1999-02-11 Genset Est 5' pour proteines secretees identifiees dans le tissu cerebral
WO1999031236A2 (fr) * 1997-12-17 1999-06-24 Genset ADNc PROLONGES POUR PROTEINES SECRETEES

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ADAMS MD ET AL: "Jurkat T-cells V Homo sapiens cDNA", EMEST DATABASE ENTRY HSZZ15367, ACCESSION NUMBER AA310233, 18 April 1997 (1997-04-18), XP002124497 *
HILLIER L ET AL: "Homo sapiens cDNA clone", EMEST DATABASE ENTRY HS859276, ACCESSION NUMBER N33859, 13 January 1996 (1996-01-13), XP002124496 *
WU, REN-LONG ET AL: "Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation.", CANCER RESEARCH, (MARCH 15, 1998) VOL. 58, NO. 6, PP. 1291-1297., XP002124498 *

Also Published As

Publication number Publication date
EP1071776A2 (fr) 2001-01-31
WO1999054460A2 (fr) 1999-10-28
JP2002531052A (ja) 2002-09-24
DE19818620A1 (de) 1999-10-28

Similar Documents

Publication Publication Date Title
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
WO1999053051A3 (fr) Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
WO1999047669A3 (fr) Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
EP1033401A3 (fr) Marqueurs de séquence exprimées et protéines humaines codées
WO1999055858A3 (fr) Sequences nucleotidiques humaines obtenues a partir d'un tissu tumoral du pancreas
WO1999006548A3 (fr) Est 5' pour proteines secretees sans specificite tissulaire
WO1999040189A3 (fr) ADNc CODANT DES PROTEINES SECRETEES
WO1999006554A3 (fr) Est 5' pour proteines secretees exprimees dans des tissus musculaires et autres tissus mesodermiques
WO1999054460A3 (fr) Sequences d'acide nucleique provenant du tissu normal de la vessie
WO1999006550A3 (fr) Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
WO1999006549B1 (fr) Est 5' pour proteines exprimees dans les testicules et autres tissus
WO1999054353A3 (fr) Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus
CA2296769A1 (fr) Facteur modifie affectant le tissu dorsal et composition a base de ce facteur
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2004096842A3 (fr) Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
WO2001068854A3 (fr) Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO2002020762A8 (fr) Molecules analogues au recepteur du tnf et ses utilisations
WO1999006553A3 (fr) Est 5' pour proteines secretees exprimees dans divers tissus
WO1999006439A3 (fr) Est 5' pour proteines secretees exprimees dans l'endoderme
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999924792

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999924792

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09673840

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999924792

Country of ref document: EP